The use of retinoids in the prevention and treatment of skin cancer

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 3, 2002, Pages 299-303

  Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Melanoma; Non melanoma skin cancer; Retinoids

Indexed keywords

BEXAROTENE; EFFUDEX; ETRETIN; ETRETINATE; FLUOROURACIL; ISOTRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE;

ACTINIC KERATOSIS; ARTICLE; CANCER DIAGNOSIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOSURGERY; DRUG EFFICACY; DRUG RESEARCH; DRUG TOLERABILITY; HEADACHE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MUSCULOSKELETAL DISEASE; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; SKIN IRRITATION; T CELL LYMPHOMA; TERATOGENICITY; UNITED STATES;

BENCHMARKING; HUMANS; ISOTRETINOIN; RETINOIDS; SKIN NEOPLASMS; TRETINOIN;

EID: 0036195075     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.3.299     Document Type: Article

References (48)

1. Cancer statistics, 2001
2. Skin cancers
3. Multivariate risk score for recurrence of cutaneous basal cell carcinomas
4. Malignant melanoma of the skin: I. The association of tumour depth and type and patient sex, age and site with survival
5. Retinoids in development
6. Vitamin A functions in the productive organs
7. Retinoids and their receptors in differentiation, embryogenesis and neoplasia
8. The molecular basis of visual excitation
9. Vitamin A and reproduction in rats
10. Retinol-binding protein: The serum transporter protein for vitamin A
11. Retinoic acid metabolism
12. Retinoic acid receptors and retinoid X receptors: Interaction with endogenous retinoic acids
13. A decade of molecular biology of retinoic acid receptors
14. Retinoic receptors in health and disease: Co-regulators and the chromatin connection
15. Retinoid X receptor and its partners in the nuclear receptor family
16. Nuclear receptor coactivators
17. Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study
18. Epidemiology of squamous cell cancer of the head and neck
19. Diet and the epidemiology of human breast cancer
20. Nutrition and experimental carcinogenesis: A review
21. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl) formamide
22. Metabolism of retinoic acid: Implications for development and cancer
23. Vitamin A and cancer
24. Retinoids, apoptosis and cancer
25. Expression of retinoic acid receptor proteins in basal cell carcinomas: An immunohistochemical analysis
26. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis
27. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
28. Etretinate in treatment of actinic keratoses
29. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro
30. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors
31. Treatment and prevention of basal cell carcinoma with oral isotretinoin
32. Retinoic acid embryopathy
33. Side effects of systemic retinoids and their clinical management
34. Long-term safety of retinoid therapy
35. Premature epiphyseal closure in a child receiving oral 13-cis retinoic acid
36. Etretinate in severe psoriasis
37. Etretinate in the treatment of actinic keratosis
38. Etretinate: Persistent serum levels after long-term therapy
39. Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: A double-blind, comparative study
40. Effect of tretinoin emollient cream on photodamaged skin: Relationship between clinical improvement and skin irritation
41. Topical tretinoin for photoaged skin
42. Effects of intensive application of retinoic acid on human skin
43. Oral bexarotene in the treatment of cutaneous T-cell lymphoma
44. Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
45. Synthetic retinoid CD437 promotes rapid apoptosis in malignant human epidermal keratinocytes and G1 arrest in their normal counterparts
46. Chemical induction of tumour cell differentiation
47. Recurrent melanoma after topical tretinoin
48. ATRA in the treatment of acute promyelocytic leukemia